| Application no. and date | 01910051.0 (espacenet) (Federated) (European Patent Register), 20010309 | | Patent/reg. no. and date | DK/EP 1267869, 20040519 | | Publication date | 20030102 | | Priority no. and date | GB 0005700, 20000309 | | EP pub. no. and date |
EP 1267869 20030102 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo Wellcome House
Berkeley Avenue
Greenford, Middlesex UB6 ONN, GB | | Applicant ref. no. | 108846 | | Inventor | CORSI, Mauro, Glaxo Wellcome SpA
Via Alessandro Fleming 2
I-37100 Verona, IT,
CONQUET, François
Inst. Bio. Cel. Morphologie, Université de Lausanne
Rue de Bugnon 9
1005 Lausanne, CH | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/197 (2006.01) , A61K 31/44 (2006.01) , A61K 45/00 (2006.01) , A61K 45/06 (2006.01) , A61P 25/30 (2006.01) , A61P 25/32 (2006.01) , A61P 25/34 (2006.01) , A61P 25/36 (2006.01) | | Title | Metabotrope glutamatreceptorantagonister til behandling af tolerance og afhængighed | | Int. application no. | GB2001001058 | | Int. publication no. | WO2001066113 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
